Wider safety window with radiolabeled somatostatin receptor antagonists over agonists

被引：0
|
作者：
Nicolas, Guillaume [1 ]
Mansi, Rosalba [1 ]
Vomstein, Sandra [1 ]
Kaufmann, Jens [2 ]
Bouterfa, Hakim [2 ]
Maecke, Helmut [3 ]
Wild, Damian [1 ]
Fani, Melpomeni [1 ]
机构：
[1] Univ Basel Hosp, Div Nucl Med, CH-4031 Basel, Switzerland
[2] Octreopharm Sci GmbH, Berlin, Germany
[3] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
335
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Higher Therapeutic Index In Vivo With Radiolabeled Somatostatin Receptor Antagonists May Broaden the Safety Window of PRRT
    Nicolas, Guillaume P.
    Mansi, Rosalba
    Vomstein, Sandra
    Kaufmann, Jens
    Bouterfa, Hakim
    Maecke, Helmut R.
    Wild, Damian
    Fani, Melpomeni
    [J]. PANCREAS, 2016, 45 (03) : 468 - 468
  • [2] Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors
    Ginj, Mihaela
    Zhang, Hanwen
    Waser, Beatrice
    Cescato, Renzo
    Wild, Damian
    Wang, Xuejuan
    Erchegyi, Judit
    Rivier, Jean
    Maecke, Helmut R.
    Reubi, Jean Claude
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (44) : 16436 - 16441
  • [3] Somatostatin receptor agonists and antagonists
    Crider, AM
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1427 - 1441
  • [4] Pharmacology of somatostatin receptor agonists and antagonists: clinical applications
    Taylor, J
    [J]. ANNALES D ENDOCRINOLOGIE, 1998, 59 : 10 - 11
  • [5] Somatostatin Receptor Imaging of Neuroendocrine Tumors: From Agonists to Antagonists
    Bodei, Lisa
    Weber, Wolfgang A.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) : 907 - 908
  • [6] Higher Tumour Uptake and Residence Time Enhance the Therapeutic Index of the Radiolabeled Somatostatin Antagonists over the Agonists: The Influence of the Peptide Mass
    Nicolas, G. P.
    Vomstein, S.
    Wild, D.
    Bouterfa, H.
    Maecke, H. R.
    Fani, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S292 - S292
  • [7] SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
    Dalm, Simone U.
    Haeck, Joost
    Doeswijk, Gabriela N.
    de Blois, Erik
    de Jong, Marion
    van Deurzen, Carolien H. M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (10) : 1609 - 1614
  • [8] Comparison of radiolabeled somatostatin receptor agonist and antagonists in a mouse model of human breast cancer
    Pourghiasian, Maral
    Zhang, Zhengxing
    Hundal-Jabal, Navjit
    Lin, Kuo-Shyan
    Benard, Francois
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [9] The Effects of Somatostatin 2 Receptor Agonists and Antagonists on a Putative Migraine Trigger Pathway
    Lambert, G. A.
    Truong, L.
    Zagami, A. S.
    [J]. HEADACHE, 2011, 51 : 58 - 58
  • [10] Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors
    Santhosh Kumar Nagarajan
    Sathya Babu
    Thirumurthy Madhavan
    [J]. Molecular Diversity, 2017, 21 : 367 - 384
12345